StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report released on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Price Performance Calithera Biosciences stock opened at $0.03 on Friday. The firm has a market cap of $146,100.00, a PE ratio of […]

Leave a Reply

Your email address will not be published.

Previous post Norquist: Why 2023 was a great year for Republicans
Next post CB Financial Services (NASDAQ:CBFV) Now Covered by StockNews.com